The New York Academy of Medicine
Paul Tanico is a seasoned finance professional with extensive experience in portfolio management and investment strategy. As the Founder and Portfolio Manager of CastleRock Investors Fund LLC since January 2022 and Castlerock Asset Management, Inc. since 1993, Tanico has established a strong presence in the investment community. Additionally, Tanico serves as the CEO and Executive Chairman of SYNAPS Dx, which developed the DISCERN™ test for Alzheimer’s Disease, and holds board positions with The WNET Group and The New York Academy of Medicine. Previous roles include research partner at Omega Advisors and portfolio manager positions at Neuberger Berman and Atlanta Sosnoff Capital. Educational credentials include a Doctor of Law (JD) from Fordham University School of Law and a Bachelor's degree in Accounting and Finance from New York University.
This person is not in any teams
This person is not in any offices
The New York Academy of Medicine
1 followers
Established in 1847, The New York Academy of Medicine is dedicated to ensuring everyone has the opportunity to live a healthy life. Through our original research, policy and program initiatives we provide the evidence base to address the structural and cultural barriers to good health and drive progress toward health equity. This work and our one-of-a-kind public programming are supported by our world class historical medical library and our Fellows program, a unique network of more than 2,000 experts elected by their peers from across the professions affecting health.